Search Results - "Shidara, Y"

Refine Results
  1. 1

    Zonal necrosis prevented by transduction of the artificial anti-death FNK protein by Asoh, S, Mori, T, Nagai, S, Yamagata, K, Nishimaki, K, Miyato, Y, Shidara, Y, Ohta, S

    Published in Cell death and differentiation (01-04-2005)
    “…Protection of cells from necrosis would be important for many medical applications. Here, we show protein transduction domain (PTD)-FNK therapeutics based on…”
    Get full text
    Journal Article
  2. 2

    Lupus anticoagulant autoantibody induces apoptosis in umbilical vein endothelial cells: involvement of annexin V by Nakamura, N, Shidara, Y, Kawaguchi, N, Azuma, C, Mitsuda, N, Onishi, S, Yamaji, K, Wada, Y

    “…The effects of lupus anticoagulant (LAC) on cultured human umbilical vein endothelial cells were studied. All five monoclonal antibodies from a patient with…”
    Get more information
    Journal Article
  3. 3

    Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis by SHIDARA, Yujiro, YAMAGATA, Kumi, KANAMORI, Takashi, NAKANO, Kazutoshi, KWONG, Jennifer Q, MANFREDI, Giovanni, ODA, Hideaki, OHTA, Shigeo

    Published in Cancer research (Chicago, Ill.) (01-03-2005)
    “…The role of mitochondrial dysfunction in cancer has been a subject of great interest and much ongoing investigation. Although most cancer cells harbor somatic…”
    Get full text
    Journal Article
  4. 4

    Isolation and purification of placental coagulation inhibitor by Shidara, Y

    Published in Nihon Sanka Fujinka Gakkai zasshi (01-12-1984)
    “…The placenta contains such thrombotic factors as tissue thromboplastin, placental factor XIII, and placental urokinase inhibitor. On the other hand, there are…”
    Get more information
    Journal Article
  5. 5

    Acting point of placental coagulation inhibitor by Shidara, Y

    Published in Nihon Sanka Fujinka Gakkai zasshi (01-01-1985)
    “…In the previous paper, the methods of purification of placental coagulation inhibitor (PCI) were reported. This paper deals with the acting point of the PCI on…”
    Get more information
    Journal Article
  6. 6

    MIDAS/GPP34, a nuclear gene product, regulates total mitochondrial mass in response to mitochondrial dysfunction by Nakashima-Kamimura, Naomi, Asoh, Sadamitsu, Ishibashi, Yoshitomo, Mukai, Yuri, Shidara, Yujiro, Oda, Hideaki, Munakata, Kae, Goto, Yu-ichi, Ohta, Shigeo

    Published in Journal of cell science (15-11-2005)
    “…To investigate the regulatory system in mitochondrial biogenesis involving crosstalk between the mitochondria and nucleus, we found a factor named MIDAS…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Classification by bagged consistent itemset rules by Shidara, Y., Kudo, M., Nakamura, A.

    “…Associative classifiers that utilize association rules have been widely studied. It has been shown that associative classifiers often outperform traditional…”
    Get full text
    Conference Proceeding
  14. 14

    Antibody to annexin V has anti-phospholipid and lupus anticoagulant properties by Nakamura, N, Kuragaki, C, Shidara, Y, Yamaji, K, Wada, Y

    Published in American journal of hematology (01-08-1995)
    “…Anti-annexin V (anti-ANXV) IgG and lupus anticoagulant (LAC) were both shown to be capable of inducing apoptosis in umbilical vein endothelial cells [Nakamura…”
    Get more information
    Journal Article
  15. 15

    Suppression of Calphobindin I (CPB I) Production in Carcinoma of Uterine Cervix and Endometrium by Karube, Akihiro, Shidara, Yoshihiro, Hayasaka, Kiyoshi, Maki, Masahiro, Tanaka, Toshinobu

    Published in Gynecologic oncology (01-09-1995)
    “…Calphobindin I (CPB I) is a member of the family of Ca 2+-dependent phospholipid binding proteins collectively termed as annexins. CPB I (Annexin V) has…”
    Get full text
    Journal Article Conference Proceeding
  16. 16

    Fundamental study of imipenem/cilastatin sodium in obstetrics and gynecology by Taguchi, K, Saito, Y, Seki, H, Murata, M, Shidara, Y, Sayama, T, Sato, Y, Isobe, K

    Published in Japanese journal of antibiotics (01-06-1986)
    “…Following results were obtained from drip intravenous administration of imipenem/cilastatin sodium (MK-0787/MK-0791) (500 mg/500 mg) by measuring concentration…”
    Get more information
    Journal Article
  17. 17

    Effects of danazol at the immunologic level in patients with adenomyosis, with special reference to autoantibodies: a multi-center cooperative study by Ota, H, Maki, M, Shidara, Y, Kodama, H, Takahashi, H, Hayakawa, M, Fujimori, R, Kushima, T, Ohtomo, K

    “…We attempted to evaluate the effects of danazol on autoantibodies, in particular, to phospholipids, and on the immune system in patients with adenomyosis…”
    Get more information
    Journal Article
  18. 18

    A Case Report: Verrucous Carcinoma of the Endometrium - The Difficulty of Diagnosis, and a Review of the Literature by Shidara, Yoshihiro, Karube, Akihiro, Watanabe, Masato, Satou, Eiju, Uesaka, Yoshinori, Matsuura, Tooru, Tanaka, Toshinobu

    “…A verrucous carcinoma is a subtype of well‐differentiated squamous‐cell carcinomas, arising in the vagina, vulva, and uterine cervix. But a verrucous carcinoma…”
    Get full text
    Journal Article
  19. 19

    Structure and expression of cDNA for an inhibitor of blood coagulation isolated from human placenta: a new lipocortin-like protein by Iwasaki, A, Suda, M, Nakao, H, Nagoya, T, Saino, Y, Arai, K, Mizoguchi, T, Sato, F, Yoshizaki, H, Hirata, M

    Published in Journal of biochemistry (Tokyo) (01-11-1987)
    “…An inhibitor of blood coagulation, a new protein with an apparent molecular weight of 34,000 and an isoelectric point of 4.9, was purified from human placental…”
    Get more information
    Journal Article
  20. 20